Duvortuxizumab Biosimilar – Anti-CD19, CD3E mAb – Research Grade

Reference:
Size

,

Isotype

scFv -h-CH2-CH3(_scFv)_h-CH2-CH3

Brand

Product type

Clonality

Expression system

Applications

,

Product nameDuvortuxizumab Biosimilar - Anti-CD19, CD3E mAb - Research Grade
SourceCAS 1831098-91-9
SpeciesChimeric,Humanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsDuvortuxizumab,JNJ-64052781,MGD011,RES192M1.2,CD19, CD3E,anti-CD19, CD3E
ReferencePX-TA1432
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypescFv -h-CH2-CH3(_scFv)_h-CH2-CH3
ClonalityMonoclonal Antibody

Description of Duvortuxizumab Biosimilar - Anti-CD19, CD3E mAb - Research Grade

General information on Anti-CD19/CD3E[Homo sapiens] (Duvortuxizumab) Monoclonal Antibody

Duvortuxizumab is investigated for the treatment of Lymphoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Duvortuxizumab Biosimilar – Anti-CD19, CD3E mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD19 Protein – Human CD19 recombinant protein
Antigen

CD19 Protein – Human CD19 recombinant protein

PX-P4004 250$
CD19 Recombinant Protein
Antigen

CD19 Recombinant Protein

PX-P4077 500$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products